126 related articles for article (PubMed ID: 27309860)
1. CD11c is upregulated in CD8+ T cells of patients with Behçet's disease.
Park YJ; Park MJ; Park S; Lee ES
Clin Exp Rheumatol; 2016; 34(6 Suppl 102):S86-S91. PubMed ID: 27309860
[TBL] [Abstract][Full Text] [Related]
2. Increased senescent CD8+ T cells in the peripheral blood mononuclear cells of Behçet's disease patients.
Yang JY; Park MJ; Park S; Lee ES
Arch Dermatol Res; 2018 Mar; 310(2):127-138. PubMed ID: 29255925
[TBL] [Abstract][Full Text] [Related]
3. Increased frequencies of interleukin-2- and interferon-gamma-producing T cells in patients with active Behçet's disease.
Sugi-Ikai N; Nakazawa M; Nakamura S; Ohno S; Minami M
Invest Ophthalmol Vis Sci; 1998 May; 39(6):996-1004. PubMed ID: 9579479
[TBL] [Abstract][Full Text] [Related]
4. Preferential activation of circulating CD8+ and gammadelta T cells in patients with active Behçet's disease and HLA-B51.
Yasuoka H; Yamaguchi Y; Mizuki N; Nishida T; Kawakami Y; Kuwana M
Clin Exp Rheumatol; 2008; 26(4 Suppl 50):S59-63. PubMed ID: 19026117
[TBL] [Abstract][Full Text] [Related]
5. Altered expression of costimulatory molecules in Behçet's disease according to clinical activity.
Sim JH; Park MJ; Park S; Lee ES
Br J Dermatol; 2011 Jun; 164(6):1285-91. PubMed ID: 21574973
[TBL] [Abstract][Full Text] [Related]
6. Serum IL-33 levels and skin mRNA expression in Behçet's disease.
Hamzaoui K; Kaabachi W; Fazaa B; Zakraoui L; Mili-Boussen I; Haj-Sassi F
Clin Exp Rheumatol; 2013; 31(3 Suppl 77):6-14. PubMed ID: 23464866
[TBL] [Abstract][Full Text] [Related]
7. Up-regulation of Th17 and related cytokines in Behçet's disease corresponding to disease activity.
Na SY; Park MJ; Park S; Lee ES
Clin Exp Rheumatol; 2013; 31(3 Suppl 77):32-40. PubMed ID: 24064012
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-2, interleukin-6 and T regulatory cells in peripheral blood of patients with Behçet's disease and recurrent aphthous ulcerations.
Pekiner FN; Aytugar E; Demirel GY; Borahan MO
J Oral Pathol Med; 2012 Jan; 41(1):73-9. PubMed ID: 21736625
[TBL] [Abstract][Full Text] [Related]
9. Influence of human recombinant interferon-alpha2a (rhIFN-alpha2a) on altered lymphocyte subpopulations and monocytes in Behcet's disease.
Treusch M; Vonthein R; Baur M; Günaydin I; Koch S; Stübiger N; Eckstein AK; Peter HH; Ness T; Zierhut M; Kötter I
Rheumatology (Oxford); 2004 Oct; 43(10):1275-82. PubMed ID: 15252211
[TBL] [Abstract][Full Text] [Related]
10. Phenotype markers and cytokine intracellular production by CD8+ gammadelta T lymphocytes do not support a regulatory T profile in Behçet's disease patients and healthy controls.
Clemente A; Cambra A; Munoz-Saá I; Crespí C; Pallarés L; Juan A; Matamoros N; Julià MR
Immunol Lett; 2010 Apr; 129(2):57-63. PubMed ID: 20167234
[TBL] [Abstract][Full Text] [Related]
11. CD11a, CD11c, and CD18 gene polymorphisms and susceptibility to Behçet's disease in Koreans.
Park SR; Park KS; Park YJ; Bang D; Lee ES
Tissue Antigens; 2014 Oct; 84(4):398-404. PubMed ID: 25155097
[TBL] [Abstract][Full Text] [Related]
12. Expression and function of inducible costimulator on peripheral blood CD4+ T cells in Behçet's patients with uveitis: a new activity marker?
Usui Y; Takeuchi M; Yamakawa N; Takeuchi A; Kezuka T; Ma J; Matsuda R; Okunuki Y; Akiba H; Goto H
Invest Ophthalmol Vis Sci; 2010 Oct; 51(10):5099-104. PubMed ID: 20445113
[TBL] [Abstract][Full Text] [Related]
13. Disturbed Th17/Treg balance, cytokines, and miRNAs in peripheral blood of patients with Behcet's disease.
Ahmadi M; Yousefi M; Abbaspour-Aghdam S; Dolati S; Aghebati-Maleki L; Eghbal-Fard S; Khabbazi A; Rostamzadeh D; Alipour S; Shabani M; Nouri M; Babaloo Z
J Cell Physiol; 2019 Apr; 234(4):3985-3994. PubMed ID: 30317557
[TBL] [Abstract][Full Text] [Related]
14. Insufficient expression of Fas antigen on helper T cells in Behçet's disease.
Nakamura S; Sugita M; Matoba H; Tanaka S; Isoda F; Ohno S
Br J Ophthalmol; 1996 Feb; 80(2):174-6. PubMed ID: 8814751
[TBL] [Abstract][Full Text] [Related]
15. Proliferative response of CD8+ gamma delta+ T cells to Streptococcus sanguis in patients with Behçet's disease.
Nishida T; Hirayama K; Nakamura S; Ohno S
Ocul Immunol Inflamm; 1998 Sep; 6(3):139-44. PubMed ID: 9785603
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-37 expression is decreased in Behçet's disease and is associated with inflammation.
Bouali E; Kaabachi W; Hamzaoui A; Hamzaoui K
Immunol Lett; 2015 Oct; 167(2):87-94. PubMed ID: 26253248
[TBL] [Abstract][Full Text] [Related]
17. Increased entry of CD4+ T cells into the Th1 cytokine effector pathway during T-cell division following stimulation in Behcet's disease.
Koarada S; Haruta Y; Tada Y; Ushiyama O; Morito F; Ohta A; Nagasawa K
Rheumatology (Oxford); 2004 Jul; 43(7):843-51. PubMed ID: 15150429
[TBL] [Abstract][Full Text] [Related]
18. Increased proportion of CD3+CD4-CD8- double-negative T cells in peripheral blood of children with Behcet's disease.
Ling E; Shubinsky G; Press J
Autoimmun Rev; 2007 Mar; 6(4):237-40. PubMed ID: 17317615
[TBL] [Abstract][Full Text] [Related]
19. Peripheral blood T cell expansions in patients with Behcet's disease.
Esin S; Gül A; Hodara V; Jeddi-Tehrani M; Dilsen N; Koniçe M; Andersson R; Wigzell H
Clin Exp Immunol; 1997 Mar; 107(3):520-7. PubMed ID: 9067527
[TBL] [Abstract][Full Text] [Related]
20. Role of new population of peripheral CD11c(+)CD8(+) T cells and CD4(+)CD25(+) regulatory T cells during acute and remission stages in rheumatoid arthritis patients.
Kao JK; Hsue YT; Lin CY
J Microbiol Immunol Infect; 2007 Oct; 40(5):419-27. PubMed ID: 17932602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
